Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in

Clinical Trial Description

The study is to assess the safety and efficacy of a new treatment for ocular surface disease associated with the use of glaucoma medications. ;

Study Design

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04067973` - Impact of Prematurity on the Optic Nerve
Completed	`NCT04828057` - Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
Not yet recruiting	`NCT06375343` - Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®	Phase 1
Completed	`NCT00346450` - Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation	Phase 3
Completed	`NCT04351100` - Efficacy of Diacerein on Ocular Surface Disease in Degenerative Arthritis Patients
Completed	`NCT03659955` - Autologous Blood Treatment for Ocular Surface Disease	N/A
Completed	`NCT04536129` - Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure	N/A
Completed	`NCT01254370` - Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease	Phase 2
Completed	`NCT00554411` - Assessing Ocular Surface Changes After Changing Glaucoma Medications	N/A
Completed	`NCT03769454` - A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers	Phase 1
Recruiting	`NCT06256770` - Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia
Completed	`NCT04673604` - From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy	N/A
Not yet recruiting	`NCT06370585` - Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF	Phase 1
Withdrawn	`NCT04735510` - Novel Use of Restasis and PROSE Devices	Phase 3
Suspended	`NCT00348114` - Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell Deficiency	Phase 2
Recruiting	`NCT04010422` - Ocular Function in Autism Spectrum Disorder
Completed	`NCT05528016` - Short and Long-term Results of Skin Versus Skin Plus Orbicularis Resection Blepharoplasty	N/A
Completed	`NCT04452279` - Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification	N/A
Completed	`NCT04535388` - LK Scleral Lens for Patients With Intractable Ocular Surface Diseases	N/A
Recruiting	`NCT06298890` - The Pattern of Dry Eye Disease After Cataract Surgery

NCT number	NCT02656394
Study type	Interventional
Source	Glia, LLC
Contact
Status	Completed
Phase	Phase 2
Start date	January 22, 2016
Completion date	December 30, 2018

Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms